The Congressionally Directed Medical Research Programs has included Hypoxia as a Fiscal Year 2026 topic area under the Peer Reviewed Medical Research Program, creating a solid federal funding opening for HIE research and related neonatal and pediatric studies focused on hypoxic injury.
The Peer Reviewed Medical Research Program, or PRMRP, supports research across congressionally-designated topic areas. For FY26, Hypoxia is listed among the eligible topic areas for multiple award mechanisms, including Discovery, Impact, Research Advancement, Technology/Therapeutic Development, Clinical Trial, Platform Clinical Translation, and Lifestyle and Applied Health Research awards. The FY26 PRMRP funding opportunities page includes the current award mechanisms, instructions, and submission deadlines.
The PRMRP Hypoxia topic area creates a meaningful pathway for HIE researchers studying neonatal and pediatric hypoxic injury to pursue federal funding. Hope for HIE strongly encourages teams in neonatology, neonatal neurology, pediatric neurology, maternal-fetal medicine, critical care, rehabilitation, developmental pediatrics, neuroimaging, therapeutic development, and outcomes research to review the opportunity and consider submitting applications.
Potential areas of alignment may include:
The FY26 PRMRP funding opportunities were released May 8, 2026. Depending on the mechanism, letters of intent or pre-applications are due in July 2026, with full application deadlines ranging from late July through September 2026.
Research teams developing applications are encouraged to involve patient-family partners early in the process to strengthen study design, feasibility, communication, outcome selection, recruitment, retention, and long-term impact. Teams can contact Hope for HIE's research staff to discuss applications further:
Connect with families, read inspiring stories, and get helpful resources delivered right to your inbox.
Connect with families, read inspiring stories, and get helpful resources delivered right to your inbox.
